BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2792 related articles for article (PubMed ID: 19430237)

  • 1. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    Surg Infect (Larchmt); 2010 Feb; 11(1):13-20. PubMed ID: 20163258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
    Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC
    J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Aug; 63(2):344-50. PubMed ID: 17693834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
    Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
    Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
    Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
    J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
    Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
    J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
    Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
    J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerns regarding the methodology of the study entitled "Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?".
    Suzuki H; Kagawa H; Iwata K
    J Trauma; 2009 Nov; 67(5):1133; author reply 1133-4. PubMed ID: 19901690
    [No Abstract]   [Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections in a surgical intensive care unit of a university hospital in Greece.
    Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
    Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
    Ramírez P; Ferrer M; Gimeno R; Tormo S; Valencia M; Piñer R; Menendez R; Torres A
    Crit Care Med; 2009 May; 37(5):1691-5. PubMed ID: 19325465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 140.